Clinical studies recruiting near Allentown

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · Lehigh Valley Hospital-Cedar Crest · National Cancer Institute (NCI) · NCT05564390 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · Lehigh Valley Hospital-Cedar Crest · National Cancer Institute (NCI) · NCT06172296 A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Phase 3 · Lehigh Center for Clinical Research · Kallyope Inc. · NCT07674654 A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Appr
Phase 2 · Lehigh Valley Health Network (Data Collection Only) · Memorial Sloan Kettering Cancer Center · NCT05534438 Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
NA · Lehigh Valley Hospital-Cedar Crest · Alliance for Clinical Trials in Oncology · NCT07091617 A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · Lehigh Valley Hospital-Cedar Crest · Children's Oncology Group · NCT04322318 Vivistim Registry for Paired VNS Therapy (GRASP)
Phase N/A · Jefferson Health - Lehigh Valley Health Network · MicroTransponder Inc. · NCT05301140 A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone
Phase 3 · Local Institution - 0359 · Celgene · NCT05519085 LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Phase 3 · Tenax Investigational Site · Tenax Therapeutics, Inc. · NCT07288398 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Lehigh Valley Hospital-Cedar Crest · NRG Oncology · NCT05174169 Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors
Phase 2 · Lehigh Valley Health Network (Data Collection Only) · Memorial Sloan Kettering Cancer Center · NCT04165772 Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
Phase 2 · Clinical Site · Intra-Cellular Therapies, Inc. · NCT06480383 Comparative Effectiveness of Online 8-session CBT vs. 1-Session Empowered Relief for Chronic Pain - The PROGRESS Study
NA · Lehigh Valley Health Network · Stanford University · NCT05612750 Pan Tumor Rollover Study
Phase 2 · Local Institution - 0037 · Bristol-Myers Squibb · NCT03899155 Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · Lehigh Valley Hospital-Cedar Crest · National Cancer Institute (NCI) · NCT04269902 Prevail Global Study
NA · Lehigh Valley Hospital - Cedar Crest · Medtronic Vascular · NCT06535854 A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed A
Phase 3 · Lehigh Valley Hospital-Cedar Crest · Children's Oncology Group · NCT04293562 A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
Phase 3 · Lehigh Center For Clinical Research · Xenon Pharmaceuticals Inc. · NCT06775379 Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Phase N/A · Lehigh Valley Hospital-Cedar Crest · Alliance for Clinical Trials in Oncology · NCT04242095 Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipol
Phase 2 · Lehigh Center for Clinical Research /ID# 273466 · AbbVie · NCT07220460 Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci
Phase 3 · Lehigh Valley Hospital-Cedar Crest · National Cancer Institute (NCI) · NCT05256225 Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidin
Phase 2 · Lehigh Valley Hospital-Cedar Crest · National Cancer Institute (NCI) · NCT05554393 Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-S
Phase 3 · Lehigh Valley Hospital-Cedar Crest · National Cancer Institute (NCI) · NCT06498635 Project: Every Child for Younger Patients With Cancer
Phase N/A · Lehigh Valley Hospital-Cedar Crest · Children's Oncology Group · NCT02402244 Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectab
Phase 2 · Lehigh Valley Hospital-Cedar Crest · NRG Oncology · NCT05327686 Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Phase 3 · Lehigh Valley Hospital-Cedar Crest · ECOG-ACRIN Cancer Research Group · NCT04566328 Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Phase 3 · Lehigh Valley Hospital-Cedar Crest · Children's Oncology Group · NCT05235165 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · Saint Luke's Cancer Center - Allentown · NRG Oncology · NCT04852887 Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
Phase N/A · Lehigh Valley Health Network · Memorial Sloan Kettering Cancer Center · NCT04291612 mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Neg
Phase 3 · Lehigh Valley Hospital-Cedar Crest · Alliance for Clinical Trials in Oncology · NCT05677490

Look up another city

Look up another condition